share_log

Aptose Biosciences Says CFO Gregory Chow to Resign

Aptose Biosciences Says CFO Gregory Chow to Resign

Aptose Biosciences稱首席財務官Gregory Chow將辭職
Dow Jones Newswires ·  2021/03/24 04:49

DJ Aptose Biosciences Says CFO Gregory Chow to Resign

DJ Aptose Biosciences稱CFO Gregory Chow將辭職

By Stephen Nakrosis

作者:斯蒂芬·納克西

Aptose Biosciences Inc. on Tuesday said Gregory Chow, the company's chief financial officer, is resigning "to pursue an opportunity at a private biopharma company."

Aptose Biosciences Inc.週二表示,該公司首席財務官周永明(Gregory Chow)將辭職,“以尋求一傢俬營生物製藥公司的機會”。

Aptose said William Rice, the company's chairman, president and chief executive will serve as chief accounting officer until a permanent replacement is announced. The company's Chief Business Officer, Jotin Marango, will assume the duties of CFO until the replacement is announced, Aptose said.

Aptose稱,公司董事長、總裁兼執行長William Rice將擔任首席會計官,直到宣佈永久繼任者。Aptose説,公司首席商務官Jotin Marango將承擔CFO的職責,直到宣佈繼任者。

Aptose also said it plans to enter into a consulting agreement with Mr. Chow that would be effective upon his March 26 departure.

Aptose還表示,計劃與周永明達成一項諮詢協議,該協議將在周永明3月26日離職後生效。

--Write to Stephen Nakrosis at stephen.nakrosis@wsj.com

--寫信給斯蒂芬·納克希爾斯,電子郵件:stehen.naksim@wsj.com

(END) Dow Jones Newswires

(完)道瓊通訊社

March 23, 2021 16:49 ET (20:49 GMT)

2021年3月23日美國東部時間16:49(格林尼治標準時間20:49)

Copyright (c) 2021 Dow Jones & Company, Inc.

版權所有(C)2021年道瓊斯公司

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論